HIGH-DOSE CYCLOPHOSPHAMIDE AND HIGH-DOSE VP-16-213 FOR RECURRENT OR REFRACTORY SMALL-CELL LUNG-CANCER - A PHASE-II STUDY

被引:8
|
作者
POSTMUS, PE
MULDER, NH
DEVRIESHOSPERS, HG
MULDER, POM
MAAS, A
MEINESZ, AF
SLEIJFER, DT
DEVRIES, EGE
机构
[1] STATE UNIV GRONINGEN HOSP,DEPT MED ONCOL,9713 EZ GRONINGEN,NETHERLANDS
[2] STATE UNIV GRONINGEN HOSP,DEPT INTENS CARE MED,9713 EZ GRONINGEN,NETHERLANDS
[3] STATE UNIV GRONINGEN,DEPT MED MICROBIOL,9113 EZ GRONINGEN,NETHERLANDS
[4] RED CROSS BLOODBANK GRONINGEN DRENTHE,9713 EZ GRONINGEN,NETHERLANDS
来源
EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY | 1985年 / 21卷 / 12期
关键词
D O I
10.1016/0277-5379(85)90239-1
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:1467 / 1470
页数:4
相关论文
共 50 条
  • [41] FEASIBILITY OF HIGH-DOSE VP-16-213 AS SINGLE AGENT OR IN COMBINATION WITH CYCLOPHOSPHAMIDE AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT)
    MULDER, NH
    MEINESZ, AF
    SLEIJFER, DT
    POSTMUS, PE
    DEVRIES, EGE
    VANDERGEEST, S
    ORIE, JLM
    VRIESENDORP, R
    NETHERLANDS JOURNAL OF MEDICINE, 1984, 27 (10): : 389 - 392
  • [42] HIGH-DOSE CISPLATIN FOR LUNG-CANCER
    BHUCHAR, VK
    LANZOTTI, VJ
    CANCER TREATMENT REPORTS, 1982, 66 (02): : 375 - 376
  • [43] ADRIAMYCIN, CYCLOPHOSPHAMIDE, AND ETOPOSIDE (VP-16-213) IN EXTENSIVE-STAGE SMALL CELL LUNG-CANCER
    MATELSKI, HW
    LOKICH, JJ
    HUBERMAN, MS
    ZIPOLI, TE
    PAUL, S
    SONNEBORN, H
    PHILIPS, D
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1984, 7 (06): : 729 - 732
  • [44] HIGH-DOSE CHEMOTHERAPY IN LUNG-CANCER
    SOUHAMI, RL
    CHEST, 1989, 96 (01) : S66 - S68
  • [45] HIGH-DOSE METHOTREXATE IN COMBINATION CHEMOTHERAPY FOR SMALL CELL LUNG-CANCER
    GRECO, FA
    HANDE, KR
    RICHARDSON, RL
    OLDHAM, RK
    RECENT RESULTS IN CANCER RESEARCH, 1980, 74 : 50 - 55
  • [46] HIGH-DOSE PILOT-STUDIES IN EXTENSIVE-STAGE SMALL-CELL LUNG-CANCER
    JOHNSON, DH
    HANDE, KR
    PORTER, LL
    HAINSWORTH, JD
    WOLFF, SN
    GRECO, FA
    SEMINARS IN ONCOLOGY, 1986, 13 (03) : 37 - 39
  • [47] CO-TRIMOXAZOLE PROPHYLAXIS DURING HIGH-DOSE CHEMOTHERAPY OF SMALL-CELL LUNG-CANCER
    FIGUEREDO, AT
    HRYNIUK, WM
    STRAUTMANIS, I
    FRANK, G
    RENDELL, S
    JOURNAL OF CLINICAL ONCOLOGY, 1985, 3 (01) : 54 - 64
  • [48] EVALUATION OF HIGH-DOSE ETOPOSIDE COMBINED WITH CISPLATIN FOR TREATING RELAPSED SMALL-CELL LUNG-CANCER
    MASUDA, N
    FUKUOKA, M
    MATSUI, K
    NEGORO, S
    TAKADA, M
    SAKAI, N
    RYU, S
    TAKIFUJI, N
    ITO, K
    KUDOH, S
    KUSUNOKI, Y
    CANCER, 1990, 65 (12) : 2635 - 2640
  • [49] REMISSION OF BRAIN METASTASES FROM SMALL-CELL LUNG-CANCER AFTER HIGH-DOSE CHEMOTHERAPY
    POSTMUS, PE
    HAAXMAREICHE, H
    VENCKEN, LM
    MEINESZ, AF
    SLEIJFER, DT
    MULDER, NH
    ANNALS OF INTERNAL MEDICINE, 1984, 101 (05) : 717 - 717
  • [50] Phase II study of high-dose cisplatin, etoposide, and cyclophosphamide for refractory ovarian cancer - Discussion
    Schlaerth, JB
    Golditch, I
    Cain, JM
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1996, 174 (06) : 1694 - 1694